These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 15688282)

  • 21. Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment.
    Maagaard A; Holberg-Petersen M; Løvgården G; Holm M; Pettersen FO; Kvale D
    J Infect Dis; 2008 Nov; 198(10):1474-81. PubMed ID: 18851688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunologic features of HIV-1-infected women on HAART at delivery.
    Ono E; Dos Santos AM; Machado DM; Succi RC; Amed AM; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2008 Jul; 74(4):236-43. PubMed ID: 18393385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD8/CD38 activation yields important clinical information of effective antiretroviral therapy: findings from the first year of the CIPRA-SA cohort.
    Glencross DK; Janossy G; Coetzee LM; Lawrie D; Scott LE; Sanne I; McIntyre JA; Stevens W
    Cytometry B Clin Cytom; 2008; 74 Suppl 1():S131-40. PubMed ID: 18228566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment.
    Kvale D; Ormaasen V; Kran AM; Johansson CC; Aukrust P; Aandahl EM; Frøland SS; Taskén K
    AIDS; 2006 Apr; 20(6):813-20. PubMed ID: 16549964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of correlation between HIV viral load and CD4+ T-cell counts in HIV/HTLV-1 co-infection in treatment naive Mozambican patients.
    Bhatt NB; Gudo ES; Semá C; Bila D; Di Mattei P; Augusto O; Garsia R; Jani IV
    Int J STD AIDS; 2009 Dec; 20(12):863-8. PubMed ID: 19948902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy.
    Benito JM; López M; Lozano S; González-Lahoz J; Soriano V
    J Infect Dis; 2008 Nov; 198(10):1466-73. PubMed ID: 18847371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunophenotypic markers and antiretroviral therapy (IMART): T cell activation and maturation help predict treatment response.
    Mildvan D; Bosch RJ; Kim RS; Spritzler J; Haas DW; Kuritzkes D; Kagan J; Nokta M; DeGruttola V; Moreno M; Landay A
    J Infect Dis; 2004 May; 189(10):1811-20. PubMed ID: 15122517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy.
    Stone SF; Price P; French MA
    HIV Med; 2005 Jul; 6(4):278-83. PubMed ID: 16011533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of human T cell lymphotropic virus type 2 coinfection on virological and immunological parameters in HIV type 1-infected patients.
    Bassani S; López M; Toro C; Jiménez V; Sempere JM; Soriano V; Benito JM
    Clin Infect Dis; 2007 Jan; 44(1):105-10. PubMed ID: 17143825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-level exposure to HIV induces virus-specific T cell responses and immune activation in exposed HIV-seronegative individuals.
    Restrepo C; Rallón NI; del Romero J; Rodríguez C; Hernando V; López M; Peris A; Lozano S; Sempere-Ortells JM; Soriano V; Benito JM
    J Immunol; 2010 Jul; 185(2):982-9. PubMed ID: 20543099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunologic profile of human immunodeficiency virus-infected patients during viral remission and relapse on antiretroviral therapy.
    Wellons MF; Ottinger JS; Weinhold KJ; Gryszowka V; Sanders LL; Edwards LJ; Gooding ME; Thomasch JR; Bartlett JA
    J Infect Dis; 2001 May; 183(10):1522-5. PubMed ID: 11319689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro induction of HIV-1 replication in resting CD4(+) T cells derived from individuals with undetectable plasma viremia upon stimulation with human T-cell leukemia virus type I.
    Moriuchi H; Moriuchi M
    Virology; 2000 Dec; 278(2):514-9. PubMed ID: 11118373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural variation in HIV infection: Monte Carlo estimates that include CD8 effector cells.
    Heffernan JM; Wahl LM
    J Theor Biol; 2006 Nov; 243(2):191-204. PubMed ID: 16876200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.
    Van den Bosch GA; Van Gulck E; Ponsaerts P; Nijs G; Lenjou M; Apers L; Kint I; Heyndrickx L; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
    J Immunother; 2006; 29(5):512-23. PubMed ID: 16971807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV replication leads to skewed maturation of CD8-positive T-cell responses in infected children.
    Montesano C; Anselmi A; Palma P; Bernardi S; Cicconi R; Mattei M; Castelli-Gattinara G; Ciccozzi M; Colizzi V; Amicosante M
    New Microbiol; 2010 Oct; 33(4):303-9. PubMed ID: 21213588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of T-lymphocyte subpopulations with immunological markers in HIV-1-infected Indian patients.
    Kaushik S; Vajpayee M; Sreenivas V; Seth P
    Clin Immunol; 2006 Jun; 119(3):330-8. PubMed ID: 16476571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Profile of T cell immune responses in HIV-infected children from Uganda.
    Ssewanyana I; Elrefaei M; Dorsey G; Ruel T; Jones NG; Gasasira A; Kamya M; Nakiwala J; Achan J; Charlebois E; Havlir D; Cao H
    J Infect Dis; 2007 Dec; 196(11):1667-70. PubMed ID: 18008251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Close link between CD4+ and CD8+ T cell proliferation defects in patients with human immunodeficiency virus disease and relationship to extended periods of CD4+ lymphopenia.
    Sieg SF; Mitchem JB; Bazdar DA; Lederman MM
    J Infect Dis; 2002 May; 185(10):1401-16. PubMed ID: 11992274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
    Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.